| α7-nAChR | α7-nicotinic acetylcholine receptor |
| 6-OHDA | 6-hydroxydopamine |
| AD | Alzheimer’s disease |
| AP | Antro-posterior |
| Cur | Curcumin |
| DA | Dopamine |
| DV | Dorso-ventral |
| I.P. | Intraperitoneal |
| LD50 | Lethal dose; 50% |
| MAO-B | monoamine oxidase type B |
| ML | Mediolateral |
| MLA | Methyllycaconitine |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| NaOH | Sodium hydroxide |
| NS | Not significant |
| SN | Substantia nigra |
| SNpc | Substantia nigra pars compacta |
| PAM | Positive allosteric modulator |
| PD | Parkinson’s disease |
| P.O | per oral |
| TH | Tyrosine hydroxylase |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.